<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiopulmonary bypass (CPB) was used during the replacement of the aortic and mitral valves in a 43-year-old female patient </plain></SENT>
<SENT sid="1" pm="."><plain>The case was complicated by the presence of a rare hypercoagulable condition called anticardiolipin (antiphospholipid) antibody syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>The course of bypass was uneventful and the patient was released from the intensive care unit on the first postoperative day </plain></SENT>
<SENT sid="3" pm="."><plain>CPB in the presence of anticardiolipin antibodies is an unusual situation that requires diligent hematological monitoring </plain></SENT>
<SENT sid="4" pm="."><plain>Since 1989 there have been only 14 reported cases of these antibodies and cardiopulmonary bypass </plain></SENT>
<SENT sid="5" pm="."><plain>Eight of these have involved valve replacements </plain></SENT>
</text></document>